144Filing Date: Oct 14, 2026
Regeneron (REGN) 144: MURPHY ANDREW J plans to sell 4,147 Common ($3.2M) (Oct 14, 2026)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001969223-26-001073
Sale Plan
MURPHY ANDREW J
Officer·Regeneron
Proposed
CommonNasdaq
Shares4.15K
Est. DateOct 14
Market Value$3.20M
BrokerUBS Financial Services, Inc.
AcquisitionExercise of Stock Options · Issuer
Acquired DateOct 13, 2026
Amount Acquired4.17K
10b5-1 Plan Adoption05/07/2026
% Outstanding0.0041%
10b5-1
Exercise / Payment Details
Paid: Oct 13, 2026Method: Net Exercise
Signature & Compliance expand_more
Notice DateOct 14, 2026
10b5-1 Plan Adoption05/07/2026
Signature /s/ UBS Financial Services Inc, as attorney-in-fact for Andrew Murphy
Issuer Info expand_more
CompanyREGENERON PHARMACEUTICALS, INC.
CIK0000872589
SEC File No.000-19034
Phone9148477000
Address777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY 10591